Krista M. Rubin

High‐dose glucocorticoids for the treatment of ipilimumab‐induced hypophysitis is associated with reduced survival in patients with melanoma

Alexander T. Faje, Donald P. Lawrence, Keith T. Flaherty et al. · Cancer · 2018 · 483 citations · Full text

Life Sciences, Oncology, Pharmacology +13

Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors

Amanda C. Guidon, Leeann B Burton, Bart K. Chwalisz et al. · Journal for ImmunoTherapy of Cancer · 2021 · 215 citations · Full text

Medicine, Neurology, Oncology +17

Impact of Age on Outcomes with Immunotherapy for Patients with Melanoma

Allison Betof Warner, Ryan David Nipp, Anita Giobbie‐Hurder et al. · The Oncologist · 2017 · 202 citations · Full text

Life Sciences, Immunology, Oncology +17

Early Use of High-Dose Glucocorticoid for the Management of irAE Is Associated with Poorer Survival in Patients with Advanced Melanoma Treated with Anti–PD-1 Monotherapy

Xue Bai, Jiani Hu, Allison Betof Warner et al. · Clinical Cancer Research · 2021 · 176 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

A phase 2 trial of dasatinib in patients with locally advanced or stage IV mucosal, acral, or vulvovaginal melanoma: A trial of the ECOG‐ACRIN Cancer Research Group (E2607)

Kevin Kalinsky, Krista M. Rubin, Donald P. Lawrence et al. · Cancer · 2017 · 125 citations · Full text

Medicine, Oncology, Pharmacology +15